BlackRock Future Health ETF BMED

Medalist Rating as of | See BlackRock Investment Hub

Morningstar’s Analysis BMED

Will BMED outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin BlackRock Future Health ETF's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BMED

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 31.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Boston Scientific Corp

4.79 199,244
Healthcare

Alnylam Pharmaceuticals Inc

4.17 173,366
Healthcare

Intuitive Surgical Inc

4.02 167,242
Healthcare

argenx SE ADR

3.30 137,367
Healthcare

Mettler-Toledo International Inc

2.84 118,211
Healthcare

West Pharmaceutical Services Inc

2.83 117,522
Healthcare

Danaher Corp

2.42 100,764
Healthcare

Amgen Inc

2.42 100,580
Healthcare

Roche Holding AG

2.28 94,682
Healthcare

UnitedHealth Group Inc

2.19 90,995
Healthcare

Sponsor Center